nimotuzumab

{
  "id": "MLC-T-ONC-005837",
  "term": "nimotuzumab",
  "field": "Oncology and biomedicine",
  "definitions": [
    "A substance being studied in the treatment of some types of cancer. Nimotuzumab binds to a protein called epidermal growth factor receptor (EGFR), which is found on some normal cells and some types of cancer cells. Blocking this protein may help keep cancer cells from growing. Nimotuzumab is a type of monoclonal antibody. Also called Theraloc.",
    "A humanized monoclonal antibody directed against the epidermal growth factor receptor (EGFR) with potential antineoplastic activity. Nimotuzumab binds to and inhibits EGFR, resulting in growth inhibition of tumor cells that overexpress EGFR. This agent may act synergistically with radiation therapy."
  ],
  "synonyms": [
    "Theraloc",
    "TheraCim hR3",
    "Thera-CIM-hr3"
  ],
  "references": [
    "NCI Dictionary of Cancer Terms",
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/nimotuzumab/"
}